WO2004082591A8 - Pharmaceutical composition for treatment of diabetes mellitus - Google Patents
Pharmaceutical composition for treatment of diabetes mellitusInfo
- Publication number
- WO2004082591A8 WO2004082591A8 PCT/IN2004/000046 IN2004000046W WO2004082591A8 WO 2004082591 A8 WO2004082591 A8 WO 2004082591A8 IN 2004000046 W IN2004000046 W IN 2004000046W WO 2004082591 A8 WO2004082591 A8 WO 2004082591A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- pharmaceutical composition
- diabetes mellitus
- mellitus
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN196/MUM/2003 | 2003-02-17 | ||
IN196MU2003 | 2003-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004082591A2 WO2004082591A2 (en) | 2004-09-30 |
WO2004082591A8 true WO2004082591A8 (en) | 2004-12-09 |
Family
ID=33017828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2004/000046 WO2004082591A2 (en) | 2003-02-17 | 2004-02-17 | Pharmaceutical composition for treatment of diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004082591A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911781B2 (en) | 2002-06-17 | 2014-12-16 | Inventia Healthcare Private Limited | Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201101809A1 (en) | 2010-12-21 | 2012-07-23 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Vildagliptin and glimepiride combinations. |
-
2004
- 2004-02-17 WO PCT/IN2004/000046 patent/WO2004082591A2/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911781B2 (en) | 2002-06-17 | 2014-12-16 | Inventia Healthcare Private Limited | Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
Also Published As
Publication number | Publication date |
---|---|
WO2004082591A2 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI350751B (en) | Pharmaceutical compositions for treating diabetes | |
EG24124A (en) | Pharmaceutical compositions for the treatment of type-II diabetes mellitus | |
PL370818A1 (en) | Dosage form for treatment of diabetes mellitus | |
IL185761A0 (en) | Pharmaceutical compositions for treating diabetes | |
IL213806A0 (en) | Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions | |
AU2002226633A1 (en) | Treatment of diabetes mellitus using vardenafil | |
IL177232A0 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
IL185277A0 (en) | Pharmaceutical compositions containing roflumilast for the treatment of diabetes | |
AU2003298841A1 (en) | Pharmaceutical compositions containing indistinguishable drug components | |
HK1087103A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
AU2003234929A1 (en) | Therapeutic agent for diabetes | |
AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
AU2003279442A1 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
AU2003292263A1 (en) | Use of substituted 2-phenylbenzimidazoles as medicaments | |
HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
EP1750698A4 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
EP1792620A4 (en) | Medicinal composition containing diabetes remedy | |
AU2003244082A1 (en) | Drug composition for blood sugar control | |
WO2004082591A8 (en) | Pharmaceutical composition for treatment of diabetes mellitus | |
AU2003212672A1 (en) | Pharmaceutical composition comprising an extract or compounds isolated from elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications | |
AU2003290418A1 (en) | Novel molecules to develop drug for the treatment of osteoporosis | |
AU2003273192A1 (en) | Compounds and compositions for the treatment of diabetes and diabetes-related disorders | |
AU2003286755A1 (en) | Benzodiazepine derivatives for the treatment of diabetes mellitus | |
HU0300983D0 (en) | Pharmaceutical composition for the preatment of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |